Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.37 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.33 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.32 |
| ▸ | GABRD | O14764 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.32 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6736880 | 0.82 | LMNA (0.41) | LMNASLC15A2EGLN1FFAR3HDAC3 | |
| SCHEMBL6741739 | 0.72 | LMNA (0.42) | LMNASLC15A2EGLN1FFAR3HDAC3 | |
| SCHEMBL7593280 | 0.72 | — | — | |
| SCHEMBL21540103 | 0.72 | FFAR3 (0.33) | LMNAFFAR3 | |
| SCHEMBL15260387 | 0.71 | LMNA (0.46) | LMNASLC15A2EGLN1FFAR3HDAC3 | |
| SCHEMBL15260388 | 0.71 | LMNA (0.46) | LMNASLC15A2EGLN1FFAR3HDAC3 | |
| SCHEMBL15274237 | 0.71 | LMNA (0.46) | LMNASLC15A2EGLN1FFAR3HDAC3 | |
| SCHEMBL951840 | 0.69 | FFAR3 (0.41) | LMNASLC15A2EGLN1FFAR3HDAC3 | |
| SCHEMBL644570 | 0.68 | EGLN1 (0.43) | LMNASLC15A2EGLN1FFAR3HDAC3 | |
| SCHEMBL22788857 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6689427-B2 | SUITABLE FOR THE DEPOSITION OF A MULTICOMPONENT METAL OXIDE THIN FILM CONTAINING A GROUP IV METAL SUCH AS TITANIUM; FOR EXAMPLE, TITANIUM BIS(4-(ETHOXY)IMINO-2-PENTANOATE) | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-02-10 | — | — | US | claimed |
| US-20020058843-A1 | Novel group IV metal precursors and a method of chemical vapor deposition using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2002-05-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058843-A1 | Novel group IV metal precursors and a method of chemical vapor deposition using the same | TLL2, TRMT1L, TLL1 | LMNA 1986/4885SLC15A2 3724/4885EGLN1 4094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.